Johnson & Johnson announced it will hold an investor conference call on Tuesday, October 14, at 8:30 a.m. Eastern Time to discuss its third-quarter financial results. The event will be led by Joaquin Duato, Chairman and Chief Executive Officer; Joseph J. Wolk, Executive Vice President and Chief Financial Officer; and Darren Snellgrove, Vice President of Investor Relations. Additional members of the executive team will participate in the question-and-answer session.
The company stated that both the webcast and presentation materials will be available through its investor relations website at www.investor.jnj.com. A replay of the webcast is expected to be posted about three hours after the conclusion of the call.
Investors can also access the conference by telephone. U.S.-based participants can dial 877-869-3847, while those outside the U.S. can use 201-689-8261. For those unable to join live, a replay will be accessible until midnight on October 28 by calling 877-660-6853 (U.S.) or 201-612-7415 (international), using conference ID number 13755498.
A press release detailing third-quarter results is scheduled for publication at approximately 6:45 a.m. Eastern Time on the day of the call.
The company also noted that information about other planned earnings calls is available on its investor website and reminded stakeholders that its fourth-quarter earnings call is set for Wednesday, January 21, 2026.
"At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/."